Radioimmunodetection with (111)In–labeled Monoclonal Antibody Nd2 in Patients with Pancreatic Cancer

This report summarizes results from an initial clinical evaluation of radioimnumodetection (RAID) in patients with pancreatic cancer using murine monoclonal antibody Nd2, directed against mucins from pancreatic cancer.Nd2 (2 mg) was labeled with (111)ln (2 mCi) and injected into 19 patients suspecte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Jpn J Cancer Res
Main Authors: Chung, Yong‐Suk, Sawada, Tetsuji, Kondo, Yasuyuki, Hirayama, Koji, Inui, Akimasa, Yamashita, Yoshito, Nakata, Bunzo, Okamura, Terue, Ochi, Hironobu, Ho, Jenny J. L., Kim, Young S., Sowa, Michio
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 1997
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5921428/
https://ncbi.nlm.nih.gov/pubmed/9197537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1997.tb00400.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados